GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.77 USD | +1.70% |
|
-0.78% | +20.80% |
| 31/05 | US FDA approves Moderna's RSV vaccine, its second marketed product | RE |
| 30/05 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
28736d863a295a71f.UJ9kT-ssJATry9UMAgIugROGcPkZN7dvjMU0mGwMgtM.GqkdAJ1mVmqOmJB6MUlA00HwJrJ7QtUl4o9H0gB-tb0Csis7s0hqdr2ynA~353c6b28967ec62a33300c31005d5c2f
